We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Ion Beam Breakthrough Kills Tumors

By Biotechdaily staff writers
Posted on 09 Feb 2006
Nonsurgical cancer therapy that kills tumors but leaves healthy surrounding tissue intact could soon become available for patients if a recent study's results ultimately become reality. More...


The Los Alamos [U.S.] National Laboratory (NM, USA) Trident laser group, working with researchers from the University of Nevada, Reno (USA) and elsewhere, has succeeded in concentrating the intensity of a laser-driven carbon ion beam into a narrow range. This study supports earlier studies led by the University of Nevada that found much higher quality laser proton beams from laser acceleration as opposed to traditional particle acceleration.

Generating carbon ion beams and limiting their spread removes the primary hurdle to improving such applications as tumor irradiation therapy. Many technologic challenges still have to be met to develop a compact particle generator that could be utilized in a hospital environment. No clinical trials are impending. This new development, however, should create new opportunities for developments in nuclear fusion applications.

The study was published in the January 26, 2006, issue of the journal Nature.



Related Links:
University of Nevada, Reno

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
New
MR-proADM Test
B•R•A•H•M•S MR-proADM KRYPTOR test
Electrolyte Analyzer
BKE-B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: iStock

Blood Test Measuring Tumor Proliferation May Guide Treatment Sequencing in Metastatic Melanoma

Metastatic melanoma remains difficult to manage because outcomes vary widely and early prognostic markers are limited. About half of patients carry a BRAF gene mutation, giving clinicians several first-line... Read more

Molecular Diagnostics

view channel
Image Credit: Adobe Stock

Comprehensive Genomic Testing Expands Treatment Options for Advanced Cancers

Selecting effective therapies for advanced cancers remains difficult because standard tumor testing often targets only a limited set of genes. As options dwindle, many patients face decisions without strong... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.